Cashback on Brokerage
Pfizer Inc is a drug manufacturers-general business based in the US. Pfizer shares (PFE) are listed on the NYSE and all prices are listed in US Dollars. Pfizer employs 78,500 staff and has a trailing 12-month revenue of around USD$46.4 billion.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Since the stock market crash in March caused by coronavirus, Pfizer's share price has had significant positive movement.
Its last market close was USD$39.15, which is 8.76% up on its pre-crash value of USD$35.72 and 40.42% up on the lowest point reached during the March crash when the shares fell as low as USD$27.88.
If you had bought USD$1,000 worth of Pfizer shares at the start of February 2020, those shares would have been worth USD$759.54 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,043.74.
|Latest market close||USD$39.15|
|52-week range||USD$28.7978 - USD$42.2003|
|50-day moving average||USD$39.3032|
|200-day moving average||USD$37.2351|
|Wall St. target price||USD$42.69|
|Dividend yield||USD$1.53 (3.94%)|
|Earnings per share (TTM)||USD$1.974|
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-06-04)||39.15|
|1 month (2021-05-12)||-1.36%|
|3 months (2021-03-12)||12.05%|
|6 months (2020-12-11)||-4.79%|
|1 year (2020-06-12)||16.00%|
|2 years (2019-06-12)||-9.12%|
|3 years (2018-06-12)||7.85%|
|5 years (2016-06-10)||10.94%|
Valuing Pfizer stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Pfizer's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Pfizer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, Pfizer shares trade at around 20x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Pfizer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8793. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Pfizer's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Pfizer's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$16.8 billion.
The EBITDA is a measure of a Pfizer's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$46.4 billion|
|Operating margin TTM||25.8%|
|Gross profit TTM||USD$33.3 billion|
|Return on assets TTM||4.6%|
|Return on equity TTM||14.03%|
|Market capitalisation||USD$222.8 billion|
TTM: trailing 12 months
There are currently 59.0 million Pfizer shares held short by investors – that's known as Pfizer's "short interest". This figure is 1.7% up from 58.0 million last month.
There are a few different ways that this level of interest in shorting Pfizer shares can be evaluated.
Pfizer's "short interest ratio" (SIR) is the quantity of Pfizer shares currently shorted divided by the average quantity of Pfizer shares traded daily (recently around 29.1 million). Pfizer's SIR currently stands at 2.03. In other words for every 100,000 Pfizer shares traded daily on the market, roughly 2030 shares are currently held short.
However Pfizer's short interest can also be evaluated against the total number of Pfizer shares, or, against the total number of tradable Pfizer shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Pfizer's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Pfizer shares in existence, roughly 10 shares are currently held short) or 0.0105% of the tradable shares (for every 100,000 tradable Pfizer shares, roughly 11 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Pfizer.
Steps to owning and managing Roblox stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Coinbase shares.
Ever wondered how to buy shares in Blue Apron? We explain how and compare a range of providers that can give you access to many brands, including Blue Apron.
Ever wondered how to buy shares in Kandi? We explain how and compare a range of providers that can give you access to many brands, including Kandi.
Ever wondered how to buy shares in B&G Foods? We explain how and compare a range of providers that can give you access to many brands, including B&G Foods.
Ever wondered how to buy shares in Ayro? We explain how and compare a range of providers that can give you access to many brands, including Ayro.
Ever wondered how to buy shares in The Children’s Place? We explain how and compare a range of providers that can give you access to many brands, including The Children’s Place.
Ever wondered how to buy shares in Tanger Factory Outlet Centers? We explain how and compare a range of providers that can give you access to many brands, including Tanger Factory Outlet Centers.
Ever wondered how to buy shares in Blockbuster? We explain how and compare a range of providers that can give you access to many brands, including Blockbuster.
Ever wondered how to buy shares in Ligand Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Ligand Pharmaceuticals.
finder.com.au is one of Australia's leading comparison websites. We compare from a wide set of banks, insurers and product issuers. We value our editorial independence and follow editorial guidelines.
finder has access to track details from the product issuers listed on our sites. Although we provide information on the products offered by a wide range of issuers, we don't cover every available product or service.
Please note that the information published on our site should not be construed as personal advice and does not consider your personal needs and circumstances. While our site will provide you with factual information and general advice to help you make better decisions, it isn't a substitute for professional advice. You should consider whether the products or services featured on our site are appropriate for your needs. If you're unsure about anything, seek professional advice before you apply for any product or commit to any plan.
Products marked as 'Promoted' or 'Advertisement' are prominently displayed either as a result of a commercial advertising arrangement or to highlight a particular product, provider or feature. Finder may receive remuneration from the Provider if you click on the related link, purchase or enquire about the product. Finder's decision to show a 'promoted' product is neither a recommendation that the product is appropriate for you nor an indication that the product is the best in its category. We encourage you to use the tools and information we provide to compare your options.
Where our site links to particular products or displays 'Go to site' buttons, we may receive a commission, referral fee or payment when you click on those buttons or apply for a product.
When products are grouped in a table or list, the order in which they are initially sorted may be influenced by a range of factors including price, fees and discounts; commercial partnerships; product features; and brand popularity. We provide tools so you can sort and filter these lists to highlight features that matter to you.
We try to take an open and transparent approach and provide a broad-based comparison service. However, you should be aware that while we are an independently owned service, our comparison service does not include all providers or all products available in the market.
Some product issuers may provide products or offer services through multiple brands, associated companies or different labelling arrangements. This can make it difficult for consumers to compare alternatives or identify the companies behind the products. However, we aim to provide information to enable consumers to understand these issues.
Providing or obtaining an estimated insurance quote through us does not guarantee you can get the insurance. Acceptance by insurance companies is based on things like occupation, health and lifestyle. By providing you with the ability to apply for a credit card or loan, we are not guaranteeing that your application will be approved. Your application for credit products is subject to the Provider's terms and conditions as well as their application and lending criteria.